4.3 Article

Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0000000000002682

Keywords

antiretroviral drugs; drug transporters; drug metabolic enzymes; HIV reservoirs; monocytes; macrophages

Funding

  1. University of Toronto, Leslie Dan Faculty of Pharmacy Internal Grant [923465]
  2. Canadian HIV Cure Enterprise Team Grant (CanCURE 1.0) - Canadian Institutes of Health Research (CIHR)
  3. CANFAR
  4. IAS [HIG-133050]
  5. National Institute of Allergy and Infectious Diseases [1R01 AI-124965]
  6. CIHR [MOP 103230, PTJ 166049]
  7. Vaccines and Immunotherapy Core of the CIHR Canadian HIV Trials Network [CTN 257, CTN PT027]
  8. Vaccines and Immunotherapy Core of the CIHR Canadian HIV Trials Network Grant [CTN 257, CTN PT027]
  9. CIHR-funded CanCURE 2.0 Team Grant [HB2-164064]

Ask authors/readers for more resources

This study investigated the expression of drug transport proteins and metabolic enzymes in monocytes and monocyte-derived macrophages of HIV-infected and uninfected individuals, suggesting that these factors may play a role in regulating intracellular concentrations of antiretroviral drugs. Further research is needed to explore the impact of these transporters on drug penetration in tissue macrophages.
Membrane-associated drug transport proteins and drug metabolic enzymes could regulate intracellular antiretroviral (ARV) drug concentrations in HIV-1 target cells such as myeloid cells. We investigated the expression of these transporters and enzymes in monocyte subsets and monocyte-derived macrophages (MDMs) isolated from peripheral blood mononuclear cells (PBMCs) of HIV-uninfected individuals (HIV-negative) and people living with HIV receiving viral suppressive antiretroviral therapy (ART; HIV+ART) and examined plasma and intracellular ARV concentrations. Monocytes were isolated from PBMCs of 12 HIV-negative and 12 HIV+ART donors and differentiated into MDMs. The mRNA and protein expression of drug transporters and metabolic enzymes were analyzed by quantitative real-time polymerase chain reaction and flow cytometry, respectively. ARV drug concentrations were quantified in plasma, PBMCs, monocytes, and MDMs by LC-MS/MS. The mRNA expression of relevant ARV transporters or metabolic enzymes, ABCB1/P-gp, ABCG2/BCRP, ABCC1/MRP1, ABCC4/MRP4, SLC22A1/OCT1, SLC29A2/ENT2, CYP2B6, CYP2D6, and UGT1A1, was demonstrated in monocytes and MDMs of 2 to 4 HIV-negative donors. P-gp, BCRP, and MRP1 proteins were differentially expressed in classical, intermediate, and nonclassical monocytes and MDMs of both HIV+ART and HIV-negative donors. Intracellular concentrations of ARVs known to be substrates of these transporters and metabolic enzymes were detected in monocytes of HIV+ART donors but were undetectable in MDMs. In this study, we demonstrated the expression of drug transporters and metabolic enzymes in monocytes and MDMs of HIV-negative and HIV+ART individuals, which could potentially limit intracellular concentrations of ARVs and contribute to residual HIV replication. Further work is needed to assess the role of these transporters in the penetration of ARVs in tissue macrophages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available